Tower Research Capital (TRC)’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267 Sell
207
-706
-77% -$1.68K ﹤0.01% 4934
2025
Q4
$2.04K Sell
913
-523
-36% -$2.27K ﹤0.01% 4595
2025
Q3
$6.98K Buy
1,436
+1,028
+252% +$5.46K ﹤0.01% 4131
2025
Q2
$2.81K Sell
408
-244
-37% -$1.68K ﹤0.01% 4589
2025
Q1
$4.34K Buy
652
+68
+12% +$500 ﹤0.01% 4273
2024
Q4
$4.08K Sell
584
-2,376
-80% -$9.8K ﹤0.01% 4522
2024
Q3
$6.33K Sell
2,960
-1,935
-40% -$4.06K ﹤0.01% 4159
2024
Q2
$9.45K Sell
4,895
-313
-6% -$605 ﹤0.01% 4251
2024
Q1
$9.11K Buy
5,208
+1,638
+46% +$3.01K ﹤0.01% 3891
2023
Q4
$6.64K Buy
3,570
+259
+8% +$496 ﹤0.01% 4718
2023
Q3
$6.72K Buy
3,311
+486
+17% +$1.2K ﹤0.01% 4565
2023
Q2
$7.57K Sell
2,825
-722
-20% -$2.03K ﹤0.01% 4552
2023
Q1
$10K Buy
3,547
+142
+4% +$514 ﹤0.01% 4395
2022
Q4
$13K Buy
3,405
+698
+26% +$2.52K ﹤0.01% 3626
2022
Q3
$10K Sell
2,707
-103
-4% -$459 ﹤0.01% 4567
2022
Q2
$13K Buy
+2,810
New +$14.8K ﹤0.01% 4225
2022
Q1
Sell
-28
Closed 6460
2021
Q4
$0 Buy
+28
New +$383 ﹤0.01% 6480
2021
Q2
Sell
-936
Closed -$25K 5763
2021
Q1
$25K Buy
936
+574
+159% +$17.6K ﹤0.01% 3714
2020
Q4
$9K Sell
362
-94
-21% -$2.24K ﹤0.01% 4397
2020
Q3
$10K Buy
+456
New +$11.6K ﹤0.01% 4102
2016
Q4
Sell
-4
Closed -$1K 4282
2016
Q3
$1K Hold
4
﹤0.01% 3347
2016
Q2
$2K Buy
4
+2
+100% +$1.05K ﹤0.01% 3943
2016
Q1
$1K Buy
+2
New +$1.18K ﹤0.01% 3752
2015
Q4
Sell
-1
Closed 4937
2015
Q3
$0 Hold
1
﹤0.01% 4613
2015
Q2
$2K Sell
1
-1
-50% -$1.94K ﹤0.01% 3779
2015
Q1
$4K Hold
2
﹤0.01% 3418
2014
Q4
$4K Hold
2
﹤0.01% 2906
2014
Q3
$5K Buy
2
+1
+100% +$2.69K ﹤0.01% 3307
2014
Q2
$3K Buy
+1
New +$3.3K ﹤0.01% 3223

Other funds holding PULM

Tower Research Capital (TRC)'s PULM Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Pulmatrix (PULM) stake by 77% in Q1 2026, selling an estimated $1.68K and leaving 207 shares worth $267. The position accounts for ﹤0.01% of the portfolio, ranked #4934.

Tower Research Capital (TRC) first reported a position in PULM in Q2 2014 and has held it in 29 quarters since. The position peaked at $25K in Q1 2021. 15 funds tracked by Wall St. Rank hold PULM as of Q1 2026.

  • Tower Research Capital (TRC) held 207 shares of Pulmatrix worth $267 as of Q1 2026.
  • Tower Research Capital (TRC) sold 706 Pulmatrix shares in Q1 2026, an estimated $1.68K.
  • Pulmatrix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4934 holding.
  • Tower Research Capital (TRC) first reported a position in Pulmatrix in Q2 2014 and has held it in 29 quarters since.
  • Tower Research Capital (TRC)'s Pulmatrix position peaked at $25K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Pulmatrix as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.